www.ijpsonline.com absorptivity of 1.71×10 4 l/mol×cm when dissolved in hydrochloric acid. Third developed method (method C) was based on the formation of yellow coloured chromogen with ferric chloride and potassium dichromate, which showed maximum absorbance at 352 nm with apparent molar absorptivity of 1.23 × 10 4 l/mol×cm. Beer's law was obeyed in the concentration range of 5-30 µg/ml. Results of analysis of all methods were validated statistically and by recovery studies.
Gatifloxacin (GFN), 1-cyclopropyl-6-fluoro-1,4-dihydro-8-of 5, 10, 15, 20, 25 and 30 µg/ml. The absorbances were methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinoline then measured at 289 nm against 0.1 M sodium hydroxide, carboxylic acid, is an advanced generation antibiotic 1 . It is and at 292 nm against 0.1 M hydrochloric acid. To used in the treatment of susceptible infections, including aliquots of stock solution, 1 ml of ferric chloride and 2 ml samples.
respiratory and urinary tract infections. It is official in of potassium dichromate were added and the volume was Martindale's complete drug reference 2 . A survey of made up to 100 ml with distilled water. The solution was literature revealed a few high performance liquid allowed for 2-3 min. The absorbance of the developed chromatographic methods for its determination in human yellow-coloured chromogen was measured at 352 nm. plasma using UV 3, 4 and tandem mass detection 5 . No spectrophotometric method has been so far reported.
For the analysis of GFN in formulations, three different Hence an attempt was made to develop simple and preparations 200 mg (Nicholas Piramal), 400 mg (Sarabhai economical spectrophotometric methods for the analysis of Piramal) and IV of 10 mg/ml strength (Nicholas Piramal) GFN in pharmaceutical preparations and biological were taken. Twenty tablets were weighed and powdered. The tablet powder equivalent to 100 mg of GFN each were weighed accurately and dissolved in 0.1 M This paper describes three simple spectrophotometric hydrochloric acid and 0.1 M sodium hydroxide separately. methods for GFN, using 0.1M hydrochloric acid (method The solutions were diluted to 100 ml using the respective A), 0.1M sodium hydroxide (method B), and ferric solvents and filtered through Whatman filter paper No. 40. chloride and potassium dichromate for the third method.
One ml of IV (10 mg/ml) solution was diluted to 10 ml In the first method, GFN exhibits the maximum with distilled water. Appropriate aliquots of solutions were absorbance at 289 nm, and in the second method it taken and analyzed for GFN, using all the three gives maximum absorbance at 292 nm. In the third procedures described earlier. method, GFN reduces ferric chloride to ferrous, which forms complex with potassium dichromate to yield a A known amount of GFN was added to 5 ml of urine yellow coloured chromogen having maximum sample. To this was added 0.5 g of lead nitrate to absorbance at 352 nm.
precipitate out the chlorides present. The solution was filtered and the excess of lead present in the filtrate was All the chemicals used were of analytical grade. Aqueous removed by adding 8 M sulphuric acid. The solution was solutions of hydrochloric acid (0.1 M), sodium hydroxide again filtered. A suitable amount of an aliquot was (0.1 M), ferric chloride (0.5%) and potassium dichromate analyzed by method C for the quantification of GFN as (0.5%) (Merck India Limited, Mumbai) were prepared in distilled water. Spectral and absorbance measurements were made on Shimadzu 1601 UV/Vis spectrophotometer with 1 cm matched quartz cells.
Working standard solutions (Hetero Drugs Limited, Chennai) were prepared by dissolving 100 mg of GFN in 100 ml of 0.1 M hydrochloric acid and in 100 ml of 0.1 M sodium hydroxide separately for methods A and B; and by dissolving 100 mg of GFN in 2-3 ml of 0.1 M hydrochloric acid and then diluting to the mark with distilled water in a 100 ml standard flask for method C. Aliquots of stock solutions were then diluted with the respective diluents separately to get final concentrations described for pure drug.
One millilitre of blood was spiked with a known amount of GFN before the addition of sodium citrate. The citrated blood was deproteinated with trichloroacetic acid and filtered. The filtrate was diluted with distilled water to 100 ml in a standard flask. An appropriate amount of an aliquot was taken, neutralized with dilute sodium hydroxide solution and analyzed by method C as described earlier.
Synthetic mixture containing talc, starch, sucrose, lactose, gelatin and magnesium stearate (50 mg each) and 50 mg of GFN was prepared, and a portion of the mixture www.ijpsonline.com dextrose, lactose and sucrose was determined by a -with respect to Y = bx + a, where 'x' is the concentration in µg/ml measuring the absorbance of a solution containing 10 µg/ containing known amount of GFN was weighed ml of GFN. An error of ±2% in the absorbance readings accurately. The drug was extracted with 0.1 M sodium was considered tolerable. The proposed method was hydroxide and filtered, and the residue was washed five found to be free from interferences by the excipients in times with 0.1 M sodium hydroxide. The filtrate and the the levels found in dosage forms. This was quite clear washings were then combined in a 100 ml calibrated flask from the data obtained on the analysis of synthetic and diluted up to the mark with distilled water, and the mixtures. The results of analysis of urine and blood amount of GFN was determined by method C as samples are shown in Table 3 . As no spectrophotometric described earlier.
method for analysis of GFN in pharmaceutical and biological samples is currently available, the data obtained The optical characteristics like molar absorptivity, by the proposed method could not be compared for its Sandell's sensitivity and the linear regression equation of validation. However, the data of analysis was supported the above-mentioned methods are shown in Table 1 .
by RSD values. Hence the developed methods were GFN exhibited maximum absorbance at 289 nm in 0.1 M found to be sensitive, accurate, precise, repeatable and sodium hydroxide, 292 nm in 0.1 M hydrochloric acid and reproducible and can be used for the routine analysis of at 352 nm by forming a complex with ferric chloride and GFN in bulk drug, formulations and biological samples. potassium dichromate. A linear correlation was found between absorbances and concentration of GFN in the www.ijpsonline.com
